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a b s t r a c t
The paper aim was to present a case of bilateral, advanced, orbital lymphoma diagnosed
in a middle aged man who was admitted in a clinical condition which almost defied
reality. The entire orbito-facial region was replaced by massive ulcero-necrotic masses
which completely distorted the normal anatomy, giving an alien-like resemblance of an
otherwise ordinary man. The patient was submitted to several imaging examinations
(head and whole body computer tomography, head MRI, laterocervical ultrasound and
elastography) and surgical biopsy. The final diagnosis was stage IVB diffuse large B-cell
lymphoma (DLBCL). Currently the patient is undergoing chemotherapy with astonishing
response (clinically visible tumoral shrinkage).
The differential diagnosis of orbital masses may be extensive, starting from inflam-
matory conditions, such as cellulitis, pseudotumor, sarcoidosis and finishing with metas-
tases from lung, renal or breast cancers. However, considering the substantial tumor
volume in this case and imaging aspects, lymphomatous origin was the first diagnostic
verified and ultimately confirmed.
The peculiarities of the case do not reside in the final diagnosis, for DLBCL is the most
common form of non-Hodgkin lymphoma in middle aged men, but its debut or spread to
orbits is rare, usually unilateral and diagnosed in less advanced stage.
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anatomy, giving an alien-like resemblance of an otherwise
ordinary man (Fig. 1). Another disturbing feature was the
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Fig. 1 – A 52-year-old man – normal appearance as opposed to clinical presentation at the moment of admittance
Fig. 2 – Computer tomography images (first row) and MRI sections (second row) displaying large, solid, enhancing orbital and
periorbital masses. The eyeballs and optic nerves appeared totally engulfed and compressed by these large masses. No bone
erosions and no endocranial extension were noted
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Fig. 3 – Right laterocervical neoplastic adenopathies: MRI, Color Doppler and USE appearance (note the mixt elasticity pattern
within afflicted lymphnodes: soft cores with stiff periphery)
a c t a h a e m a t o l o g i c a p o l o n i c a 4 5 ( 2 0 1 4 ) 2 8 9 – 2 9 3 291The patient stated that his eyes started swelling 4 months
prior to presentation and although he had lost completely
his visual function during this interval, he chose to remain
home, assisted by relatives and motivating the lack of
financial means and medical insurance. He was brought to
ER unit only when the orbital hemorrhage could not be
autonomously resolved.
The head CT and MRI revealed that the entire periorbitar
space and both orbits were occupied by large, moderately
enhancing masses with relatively homogeneous aspect,
with the exception of a few necrotic, abscess-like middle
areas. The eyeballs and optic nerves appeared totally
engulfed and compressed by these large masses, but with
no sign of infiltration. No bone ersosions or endocranial
extension was noted (Fig. 2). However several bilateral
laterocervical pathologic lymphnodes were detected.The laterocervical adenopathies were further studied
using conventional ultrasound (gray scale and Doppler
mode) and free-hand elastography (USE). All analyzed fea-
tures were consistent with malignancy: round shape, hypoe-
choic structure, no echogenic hillum, necrotic areas
included, more than three vascular pedicles per lymphnode.
Elastography (Hitachi 8500 EUB machine) revealed a rigid
aspect in the periphery of affected lymphnodes with soft
cores corresponding to necrotic areas (Fig. 3).
Body CT showed homogeneous hepatosplenomegaly and
few retroperitoneal adenopathies. No pathologic lymph-
nodes or masses were noted within the thorax.
The patient was sent initially to an oral-maxilofacial
surgery service for haemostasis and wound specialized
treatment. A biopsy was performed from the periorbitar
swellings.
Fig. 4 – The pathology report indicated a large B cell diffuse lymphoma (from right to left large cell lymphomatous infiltrate,
with numerous mitoses, intense positive staining for CD20 and Ki67, negative staining for CD10 and CD5)
Fig. 5 – Post 4th cycle of R-CHOP chemotherapy: clinical
proof of tumoral shrinkage
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aspect and the immunohistochemistry tests correspond
most likely to a large B cell diffuse lymphoma (DLBCL) not
otherwise specified: large cell lymphomatous infiltrate, with
numerous mitoses, LCA positive staining, intense positive
staining for CD20 and Ki67, negative staining for CD10 and
CD5 (Fig. 4). Further laboratory tests excluded a HIV,
Epstein–Barr or Chlamidia trachomatis infection. A bone
marrow aspiration was performed revealing lymphomatous
neoplastic cells.
The patient was also submitted to a lumbar punction to
check for lymphomatous cells within the spinal fluid. CSF
proved to be negative for malignant cells. However the
patient was given Methotrexate and Cytosar as intratechal
prophilaxis treatment. Oncologic therapy also included
Rituximab and CHOP. After 4 chemotherapy cycles, the
clinical outcome seemed optimistic since there was clinical
proof of tumor shrinkage (Fig. 5) and biological tests were
still within tolerable limits. Unfortunately, in spite of psy-
chiatric and psychological assistance, the patient and his
relatives refused any form of treatment after the 4th
chemotherapy cycle and went home. No further data about
his status have come yet to our knowledge.
Discussion
Orbital lymphoma and lymphoma of the orbital adnexae are
relatively rare lymphomas, representing less than 2% of all
lymphomas and have most likely a B cell lineage rather
than T or NK cell origin [1, 2].
True primary orbital lymphomas are very rare (less than
0.1% of all lymphomas), usually unilateral, low grade orindolent and derive from mucosa associated lymphoid
tissue (MALT). Their outcome is often favorable and diseases
may be locally controlled with radiotheraphy [1–4].
Secondary orbital lymphomas are sensibly more frequent
(4.7%) and represent an extension of an aggressive systemic
disease, usually DLBCL. They also tend to develop unilater-
ally and are treated using a combination of chemo-,
immune- and radiotherapy [2–5].
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orbital involvement. On CT and MRI orbital lymphoma
appears as a rather circumscribed mass, with homogeneous
structure, moderately enhancing post intravenous contrast,
molding to the eyeball, optic nerve and facial bones [3].
Appreciating endocranial extension, especially the meninges
is essential for further therapy management which may
include high Methotrexate doses if central nervous system
is affected.
In our case the clinical presentation was striking due to
bilateral orbital and periorbital involvement with large,
facial distorting masses. We may speculate that the onset of
lymphoma was possibly extranodal, within orbital or perior-
bital soft tissue and in the last few months the neglected
disease becomes systemic with nodal, visceral and bone
marrow involvement. From an imaging point of view,
sectional imaging features were quite similar with those
described in literature [3]. The novelty resides in ultrasound
elastography revealing a combined elasticity pattern within
afflicted lymphnodes: soft cores with stiff periphery.
Presentation of DLBCL can be quite heterogeneous
when it comes to biological, morphological and genetical
factors. 70% of DLBCL may be positive for BCL-6, 30–60%
positive for CD 10 and 35–65% positive for MUM1/IRF4.
Coexpression of MUM 1 and BCL-6 antigens may be found
in 50% of diffuse non-Hodgkin lymphomas with large
B cells. In our case, at the moment of diagnosis the
Pathology Department could not perform tests for BCL
6 and IRF4/MUM 1 antigens. However due to a rather
characteristic morphology in conjunction with positive
staining for pan B lymphoma markers: CD 20 and CD 79a
our pathologists indicated a most likely DLBCL NOS
diagnosis. Other diagnostic possibilities would have been:
non-Hodgkin plasmablastic lymphoma (which may have
positive staining for CD 138 – again, not performed in our
case) or with gray zone lymphoma (mixed B cell plus
Burkitt features: positive staining for BCL-6 or t(14;18),
positive staining BCL 2, ki 67 less than 95% of all tumoral
cells). Nodular lymphocyte predominant Hodgkin's lym-
phoma (NLPHL) may be also considered if positive stain-
ing for CD 13 and CD 30. The anaplastic variant of DLBCL
NOS may be easily superposable from a morphologic point
of view with anaplastic T cell lymphoma which is inten-
sely positive for CD 30 (ki-1). It is important to mention
that most of those subentities of lymphomas benefit from
the same therapeutical approach which is mainly based
on staging and clinical presentation.
Among other malignant differential diagnosis we should
also include melanoma (positive staining for S100 and HMN-
45) and carcinoma which may present large, atypical cells
with positive staining for cytokeratin.
Differential diagnostic at presentation could also have
included non-malignant conditions such as a form of orbital
and periorbital cellulitis [5], but the clearly neoplasticlaterocervical and abdominal adenopathies shifted the diag-
nostic suspicion toward lymphoma from the first hours after
admittance.
If the patient had been compliant to treatment, the
oncologic team would have also included orbit radiation
therapy. Unfortunately the patient will remain forever
deprived of his visual function and overall prognosis is poor,
with a 5 year survival rate, less than 30% even if the
treatment would have been completely administered [6].
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